American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II

22 June 2020 - 24 June 2020

Flat-dose nivolumab well-tolerated, active for advanced NSCLC in Asians

14 Jul 2020 by

Flat-dose nivolumab, administered as a 30-minute infusion, is well tolerated and active in Asian patients with previously treated advanced non-small-cell lung cancer (NSCLC), according to results of the phase IIIb CheckMate 870 study.

Flat-dose nivolumab well-tolerated, active for advanced NSCLC in Asians

14 Jul 2020

MRI-first prostate cancer screening cost-effective with benefits

13 Jul 2020 by

An MRI-first diagnostic pathway, combined with risk-tailored screening, is shown to improve the benefit-to-harm profile and cost-effectiveness of screening for prostate cancer (PCa), according to results of a recent lifetable modelling study presented at AACR 2020 Virtual Meeting II.

MRI-first prostate cancer screening cost-effective with benefits

13 Jul 2020